{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:22:44Z","timestamp":1790076164332,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1RR029882"],"award-info":[{"award-number":["UL1RR029882"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jaci.2015.07.041","type":"journal-article","created":{"date-parts":[[2015,9,27]],"date-time":"2015-09-27T02:09:24Z","timestamp":1443319764000},"page":"1822-1829.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels"],"prefix":"10.1016","volume":"137","author":[{"given":"Kusumam","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baby G.","family":"Tholanikunnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Bork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen P.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2015.07.041_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1 inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2015.07.041_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mai.2000.108106","article-title":"Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema","volume":"106","author":"Binkley","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib3","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","article-title":"Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor","volume":"343","author":"Dewald","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2015.07.041_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaci.2009.03.038","article-title":"Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy","volume":"124","author":"Bork","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/509899","article-title":"Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III","volume":"79","author":"Cichon","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2015.07.041_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MBC.0b013e32832811f8","article-title":"Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr 309 lys","volume":"20","author":"Bork","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jaci.2015.07.041_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.amjmed.2007.08.021","article-title":"Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course","volume":"120","author":"Bork","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2015.07.041_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S1081-1206(10)60369-9","article-title":"Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks [letter]","volume":"103","author":"Bouillet","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.anai.2011.09.020","article-title":"Treatment of an attack of type III hereditary angioedema with ecallantide [letter]","volume":"108","author":"Cronin","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Clinical practice. Hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2015.07.041_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/all.12520","article-title":"A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes","volume":"70","author":"Joseph","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2015.07.041_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaci.2013.03.026","article-title":"Factor XII independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II","volume":"132","author":"Joseph","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.anai.2009.11.014","article-title":"Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis","volume":"104","author":"Joseph","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2015.07.041_bib15","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/S0021-9258(18)89258-4","article-title":"Distribution of plasma kallikrein between C1-inhibitor and \u03b12-macroglobulin in plasma utilizing a new assay for \u03b12-macroglobulin-kallikrein complexes","volume":"260","author":"Harpel","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.07.041_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1432-1033.1976.tb10875.x","article-title":"Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma","volume":"69","author":"Collen","year":"1976","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jaci.2015.07.041_bib17","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.V66.5.1086.1086","article-title":"\u03b22-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway","volume":"66","author":"Schousboe","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.07.041_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0049-3848(89)90069-8","article-title":"Purification and characterization of plasma protein C inhibitor","volume":"55","author":"Espana","year":"1989","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaci.2015.07.041_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1081-1206(10)60860-5","article-title":"Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"98","author":"Malde","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1073\/pnas.022626899","article-title":"Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of Factor XII","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2015.07.041_bib21","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1084\/jem.138.6.1564","article-title":"Activation of Hageman factor in\u00a0solid\u00a0and\u00a0fluid phases: a critical role of kallikrein","volume":"138","author":"Cochrane","year":"1973","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.07.041_bib22","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0021-9258(19)68105-6","article-title":"The cleavage and formation of activated Hageman factor by autodigestion and by kallikrein","volume":"257","author":"Dunn","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.07.041_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1083\/jcb.94.3.631","article-title":"Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators","volume":"94","author":"Levin","year":"1982","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2015.07.041_bib24","first-page":"1271","article-title":"Reduced PAI-1 activities in patients with angioedema (AE) due to C1 inhibitor deficiency [abstract]","volume":"65","author":"Bork","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2015.07.041_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2249.2011.04541.x","article-title":"Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency","volume":"167","author":"Van Geffen","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","article-title":"Plasminogen activator inhibitor type I deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Hemophilia"},{"key":"10.1016\/j.jaci.2015.07.041_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2011.07.002","article-title":"A novel mutation in the\u00a0coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor","volume":"141","author":"Bork","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib28","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1111\/hae.12519","article-title":"Characterization of a partial exon 9\/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor","volume":"20","author":"Bork","year":"2014","journal-title":"Hemophilia"},{"key":"10.1016\/j.jaci.2015.07.041_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2013.08.001","article-title":"Novel duplication in the F12 gene in a patient with recurrent angioedema","volume":"149","author":"Kiss","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib30","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1016\/S0021-9258(20)79699-7","article-title":"Autoactivation of human Hageman factor: demonstration utilizing a synthetic substrate","volume":"255","author":"Silverberg","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.07.041_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1172\/JCI107597","article-title":"Fletcher factor deficiency: a diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation","volume":"53","author":"Weiss","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2015.07.041_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/bi00297a016","article-title":"Kinetics of activation and autoactivation of human factor XII","volume":"23","author":"Tankersley","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaci.2015.07.041_bib33","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI77139","article-title":"Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III","volume":"125","author":"Bj\u00f6rkqvist","year":"2015","journal-title":"J Clin Invest"},{"issue":"suppl","key":"10.1016\/j.jaci.2015.07.041_bib34","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2500\/aap.2012.33.3627","article-title":"Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel","volume":"33","author":"Zuraw","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2015.07.041_bib35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood.V69.2.460.460","article-title":"Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors","volume":"69","author":"Kruithof","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.07.041_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642556","article-title":"Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states","volume":"59","author":"Kruithof","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2015.07.041_bib37","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1084\/jem.136.6.1378","article-title":"The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator","volume":"136","author":"Kaplan","year":"1972","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.07.041_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-2776(04)86005-X","article-title":"Formation of Bradykinin: a major contributor to the innate inflammatory response","volume":"86","author":"Joseph","year":"2005","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaci.2015.07.041_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0049-3848(83)90244-X","article-title":"A comparison of the abilities of plasma kallikrein, \u03b2-factor XIIa, factor XI and urokinase to activate plasminogen","volume":"28","author":"Miles","year":"1983","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaci.2015.07.041_bib40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V66.4.835.835","article-title":"Tissue plasminogen activator release in\u00a0vitro in response to vasoactive agents","volume":"66","author":"Smith","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.07.041_bib41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0038-1656000","article-title":"Selective stimulation of tissue-type plasminogen activator (tPA) in\u00a0vivo by infusion of bradykinin","volume":"77","author":"Brown","year":"1997","journal-title":"Thromb Haemost"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915011045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915011045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:57:09Z","timestamp":1758790629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674915011045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0091674915011045"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2015.07.041","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2015.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}